ID

34408

Description

Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT01241708

Lien

https://clinicaltrials.gov/show/NCT01241708

Mots-clés

  1. 17/01/2019 17/01/2019 -
  2. 01/10/2020 01/10/2020 -
  3. 05/10/2020 05/10/2020 - Sarah Riepenhausen
Détendeur de droits

GSK group of companies

Téléchargé le

17 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Multiple Myeloma NCT01241708

Eligibility Multiple Myeloma NCT01241708

Criteria
Description

Criteria

confirmed diagnosis of multiple myeloma with either durie-salmon stage i, ii, or iii or iss stage i, ii or iii, less than 12 months since initiation of systemic therapy
Description

ID.1

Type de données

boolean

≥8x106 cd34+cells/kg available in cryopreservation in aliquots appropriate for tandem transplants
Description

ID.2

Type de données

boolean

age: 18-75 years at time of transplantation
Description

ID.3

Type de données

boolean

kps 70-100%
Description

ID.4

Type de données

boolean

recovery from complications of prior therapies
Description

ID.5

Type de données

boolean

gender: there is no gender restriction
Description

ID.6

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
diagnosis other than multiple myeloma
Description

ID.7

Type de données

boolean

chemotherapy or radiotherapy within 8 days of initiating treatment in this study
Description

ID.8

Type de données

boolean

prior autologous or allogeneic transplantation (except as enrolled into this study)
Description

ID.9

Type de données

boolean

uncontrolled bacterial, viral, fungal or parasitic infections
Description

ID.10

Type de données

boolean

Similar models

Eligibility Multiple Myeloma NCT01241708

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
ID.1
Item
confirmed diagnosis of multiple myeloma with either durie-salmon stage i, ii, or iii or iss stage i, ii or iii, less than 12 months since initiation of systemic therapy
boolean
ID.2
Item
≥8x106 cd34+cells/kg available in cryopreservation in aliquots appropriate for tandem transplants
boolean
ID.3
Item
age: 18-75 years at time of transplantation
boolean
ID.4
Item
kps 70-100%
boolean
ID.5
Item
recovery from complications of prior therapies
boolean
ID.6
Item
gender: there is no gender restriction
boolean
Item Group
C0680251 (UMLS CUI)
ID.7
Item
diagnosis other than multiple myeloma
boolean
ID.8
Item
chemotherapy or radiotherapy within 8 days of initiating treatment in this study
boolean
ID.9
Item
prior autologous or allogeneic transplantation (except as enrolled into this study)
boolean
ID.10
Item
uncontrolled bacterial, viral, fungal or parasitic infections
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial